SK4332000A3 - Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides - Google Patents
Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides Download PDFInfo
- Publication number
- SK4332000A3 SK4332000A3 SK433-2000A SK4332000A SK4332000A3 SK 4332000 A3 SK4332000 A3 SK 4332000A3 SK 4332000 A SK4332000 A SK 4332000A SK 4332000 A3 SK4332000 A3 SK 4332000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- acid
- protecting group
- group
- mixture
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6171997P | 1997-10-10 | 1997-10-10 | |
PCT/US1998/021326 WO1999019294A1 (en) | 1997-05-14 | 1998-10-09 | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
SK4332000A3 true SK4332000A3 (en) | 2000-12-11 |
Family
ID=22037674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK433-2000A SK4332000A3 (en) | 1997-10-10 | 1998-10-09 | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
Country Status (18)
Country | Link |
---|---|
US (1) | US6180759B1 (pt) |
EP (1) | EP1030831A4 (pt) |
JP (1) | JP2001519411A (pt) |
KR (1) | KR20010024467A (pt) |
CN (1) | CN1278791A (pt) |
AP (1) | AP1057A (pt) |
AU (1) | AU738114B2 (pt) |
BG (1) | BG104408A (pt) |
BR (1) | BR9814068A (pt) |
CA (1) | CA2306823A1 (pt) |
EA (1) | EA002724B1 (pt) |
HU (1) | HUP0003788A3 (pt) |
IL (1) | IL135553A0 (pt) |
NO (1) | NO20001793L (pt) |
OA (1) | OA11369A (pt) |
PL (1) | PL340915A1 (pt) |
SK (1) | SK4332000A3 (pt) |
ZA (1) | ZA989241B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1491942A (zh) * | 1996-08-21 | 2004-04-28 | ���µ�˹ҩ����Ʒ��˾ | N-[n-n-(4-(哌啶-4-基)丁酰基)-n-乙基甘氨酰基]化合物的不吸湿的稳定结晶形式 |
CN100422147C (zh) * | 2002-11-01 | 2008-10-01 | 北京天衡药物研究院 | 一种制备0-取代磺酰酪氨酸类化合物的方法 |
KR100841409B1 (ko) * | 2003-12-16 | 2008-06-25 | 에스케이케미칼주식회사 | 암로디핀 겐티세이트 염과 이의 제조방법 |
CN103254265B (zh) * | 2012-02-21 | 2016-07-13 | 上海希迈医药科技有限公司 | 醋酸阿比特龙三氟乙酸盐及其制备方法和应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1042487A (en) * | 1964-06-25 | 1966-09-14 | Ici Ltd | Polypeptide derivatives |
JPS6322081A (ja) * | 1986-07-11 | 1988-01-29 | Kissei Pharmaceut Co Ltd | 新規なアミノ酸誘導体 |
CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
IE902238A1 (en) * | 1989-06-30 | 1991-01-16 | Abbott Lab | Tetrapeptide type-b cck receptor ligands |
IE914334A1 (en) * | 1990-12-17 | 1992-06-17 | Black James Foundation | Tetrapeptide derivatives and analogues |
US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
HU222248B1 (hu) * | 1993-10-15 | 2003-05-28 | Aventis Pharmaceuticals Inc. | Trombózis elleni hatású (aza-cikloalkil)-alkanoil-peptidek, -pszeudopeptidek és ezeket a vegyületeket tartalmazó gyógyászati készítmények |
GB9516994D0 (en) * | 1995-08-18 | 1995-10-18 | Iaf Biochem Int | Solution synthesis of peripheral acting analgestic opioid tetrapeptides |
EP0768384B1 (en) * | 1995-10-11 | 2001-06-13 | Holland Sweetener Company V.o.F. | Improved enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester |
CN1491942A (zh) * | 1996-08-21 | 2004-04-28 | ���µ�˹ҩ����Ʒ��˾ | N-[n-n-(4-(哌啶-4-基)丁酰基)-n-乙基甘氨酰基]化合物的不吸湿的稳定结晶形式 |
NL1005808C2 (nl) * | 1997-04-14 | 1998-10-19 | Dsm Nv | Hexahydro-aspartaamamiden en werkwijze voor de bereiding ervan. |
-
1998
- 1998-10-09 JP JP2000515867A patent/JP2001519411A/ja active Pending
- 1998-10-09 IL IL13555398A patent/IL135553A0/xx unknown
- 1998-10-09 HU HU0003788A patent/HUP0003788A3/hu unknown
- 1998-10-09 CN CN98810983A patent/CN1278791A/zh active Pending
- 1998-10-09 ZA ZA989241A patent/ZA989241B/xx unknown
- 1998-10-09 KR KR1020007003829A patent/KR20010024467A/ko not_active Application Discontinuation
- 1998-10-09 BR BR9814068-0A patent/BR9814068A/pt not_active IP Right Cessation
- 1998-10-09 PL PL98340915A patent/PL340915A1/xx unknown
- 1998-10-09 CA CA002306823A patent/CA2306823A1/en not_active Abandoned
- 1998-10-09 EA EA200000399A patent/EA002724B1/ru not_active IP Right Cessation
- 1998-10-09 EP EP98953345A patent/EP1030831A4/en not_active Withdrawn
- 1998-10-09 AP APAP/P/2000/001781A patent/AP1057A/en active
- 1998-10-09 SK SK433-2000A patent/SK4332000A3/sk unknown
- 1998-10-09 AU AU10746/99A patent/AU738114B2/en not_active Ceased
-
2000
- 2000-03-31 OA OA1200000096A patent/OA11369A/en unknown
- 2000-04-06 NO NO20001793A patent/NO20001793L/no not_active Application Discontinuation
- 2000-04-07 US US09/544,680 patent/US6180759B1/en not_active Expired - Fee Related
- 2000-05-08 BG BG104408A patent/BG104408A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
ZA989241B (en) | 1999-06-04 |
EA002724B1 (ru) | 2002-08-29 |
OA11369A (en) | 2004-01-27 |
NO20001793D0 (no) | 2000-04-06 |
AU1074699A (en) | 1999-05-03 |
CA2306823A1 (en) | 1999-04-22 |
JP2001519411A (ja) | 2001-10-23 |
HUP0003788A3 (en) | 2001-05-28 |
AU738114B2 (en) | 2001-09-06 |
NO20001793L (no) | 2000-04-06 |
BR9814068A (pt) | 2000-09-26 |
BG104408A (bg) | 2000-12-29 |
KR20010024467A (ko) | 2001-03-26 |
EP1030831A1 (en) | 2000-08-30 |
PL340915A1 (en) | 2001-03-12 |
HUP0003788A2 (hu) | 2001-04-28 |
EA200000399A1 (ru) | 2000-10-30 |
CN1278791A (zh) | 2001-01-03 |
US6180759B1 (en) | 2001-01-30 |
AP2000001781A0 (en) | 2000-06-30 |
AP1057A (en) | 2002-04-08 |
IL135553A0 (en) | 2001-05-20 |
EP1030831A4 (en) | 2003-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2515975C (en) | Peptide derivatives having .beta.-secretase inhibitory activity | |
JP5789260B2 (ja) | C型肝炎ウイルスのプロテアーゼ阻害薬の調製方法 | |
CN114685646B (zh) | 一种多肽侧链类似物的制备方法及其应用 | |
CA2315222A1 (en) | Branched building units for synthesizing cyclic peptides | |
SK4332000A3 (en) | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides | |
JPH0647599B2 (ja) | ヘプタノイル―Glu―Asp―Ala―アミノ酸系免疫賦活薬 | |
WO1993006127A1 (en) | Novel amino acid prodrug renin inhibitors | |
CA2412787A1 (en) | Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide | |
KR20160120345A (ko) | H-inp-(d)bal-(d)trp-phe-apc-nh2의 액체상 합성을 위한 공정, 및 이들의 약학적으로 허용 가능한 염들 | |
CZ20001296A3 (cs) | Způsob přípravy azacykloalkylalkanoylpseudotetrapeptidů | |
EP1226158B1 (en) | Process for preparing peptide intermediates | |
WO1999019294A1 (en) | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides | |
JP2000044595A (ja) | フェネチルアミン誘導体 | |
JPWO2003082819A1 (ja) | N−フェニル−n−(4−ピペリジニル)アミド誘導体 | |
JPH03500880A (ja) | レニン阻害剤、その製造方法、その使用のための方法およびそれを含有する組成物 | |
JPWO2012108408A1 (ja) | ジペプチド及びトリペプチドの製造方法 | |
KR900004648B1 (ko) | 펩타이드 유도체의 제조방법 | |
MXPA00003470A (es) | Procedimientos para preparar azacicloalquilalcanoil pseudotetrapeptidos | |
JP3554399B2 (ja) | ペプチド誘導体 | |
JPH0597789A (ja) | α−ヒドロキシグリシンアミド誘導体及びその製造方法 | |
KR820001616B1 (ko) | 테트라펩타이드의 제조방법 | |
JPH10330399A (ja) | 神経伝達ポリペプチド | |
JPH0339078B2 (pt) |